fbpx
(2 customer reviews)

Semax, 30mg

$41.99

Semax is a peptide drug based on a fragment of the adrenocorticotropic hormone (ACTH).

In Russia, Semax is used as a medication for the prevention and treatment of circulatory disorders including stroke. Semax is listed on the Russian List of Vital & Essential Drugs, a reference of key medications which is reviewed and approved by the Russian government.

Semax is also used as a nootropic, or cognitive enhancer, due to evidence that Semax can enhance memory performance and reduce the negative effects of stress.

In stock

Category:

Description

WARNING: Our products are very potent chemicals. These products are NOT for human or animal consumption and can be harmful if ingested. Our products are for laboratory research use only. These products should only be handled by licensed, qualified professionals.

Semax is a peptide drug based on a fragment of the adrenocorticotropic hormone (ACTH).

In Russia, Semax is used as a medication for the prevention and treatment of circulatory disorders including stroke. Semax is listed on the Russian List of Vital & Essential Drugs, a reference of key medications which is reviewed and approved by the Russian government.

Semax is also used as a nootropic, or cognitive enhancer, due to evidence that Semax can enhance memory performance and reduce the negative effects of stress.

Semax.png

Molecular Formula: C37H51N9O10S
Chemical Names:

Semax

Pro-gly-pro-acth (4-7)

Molecular Weight: 813.9 g/mol
Sources
  1. Quach, Helen. “Top 7 Uses of Semax (Cognitive Enhancement & More).” SelfHacked, SelfHacked, 30 May 2019, selfhacked.com/blog/all-about-semax/.
  2. “Semax.” National Center for Biotechnology Information. PubChem Compound Database, U.S. National Library of Medicine, pubchem.ncbi.nlm.nih.gov/compound/122178.

2 reviews for Semax, 30mg

  1. Emma

    Love the labels and packaging. Product works really well too

  2. Martin

    Ordered on a whim and i’m very glad i did. Will be back

Add a review

Your email address will not be published. Required fields are marked *